Skip to main content

Photodamaged Skin

4
Pipeline Programs
5
Companies
10
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
3
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
2 programs
1
1
tretinoin 0.05% lotionPhase 41 trial
Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light TherapyPhase 2/31 trial
Active Trials
NCT07686198Not Yet Recruiting20Est. Jan 2027
NCT04096742Unknown40Est. Dec 2021
Pfizer
PfizerNEW YORK, NY
1 program
1
ImedeenPhase 41 trial
Active Trials
NCT01787461Completed194Est. Mar 2014
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
1
tretinoinPhase 45 trials
Active Trials
NCT01313728Completed26Est. Jan 2011
NCT00952523Completed162Est. Oct 2009
NCT00919191Completed26Est. May 2009
+2 more trials
Galderma
GaldermaTX - Dallas
1 program
Sculptra and Alastin Restorative Skin ComplexN/A1 trial
Active Trials
NCT05963204Completed21Est. Mar 2024
ReVision Therapeutics
ReVision TherapeuticsNJ - Ridgewood
1 program
Topical Body Firming MoisturizerN/A1 trial
Active Trials
NCT04065035Completed46Est. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Fitzpatrick Companytretinoin 0.05% lotion
PfizerImedeen
Bausch Healthtretinoin
Bausch Healthtretinoin
Bausch Healthtretinoin
Bausch Healthtretinoin
Bausch Healthtretinoin
Fitzpatrick CompanyRight Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy
GaldermaSculptra and Alastin Restorative Skin Complex
ReVision TherapeuticsTopical Body Firming Moisturizer

Clinical Trials (10)

Total enrollment: 807 patients across 10 trials

NCT04096742Fitzpatrick Companytretinoin 0.05% lotion

Altreno for Chest Rejuvenation

Start: Aug 2019Est. completion: Dec 202140 patients
Phase 4Unknown

A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure

Start: Jan 2013Est. completion: Mar 2014194 patients
Phase 4Completed

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

Start: Dec 2010Est. completion: Jan 201126 patients
Phase 4Completed

Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face

Start: Jul 2009Est. completion: Oct 2009162 patients
Phase 4Completed

Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face

Start: Apr 2009Est. completion: May 200926 patients
Phase 4Completed

A Study of Different Use Regimens Using Two Acne Treatments

Start: Feb 2009Est. completion: Sep 2009247 patients
Phase 4Completed

Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.

Start: Jan 2008Est. completion: Feb 200825 patients
Phase 4Completed
NCT07686198Fitzpatrick CompanyRight Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy

Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms

Start: Jul 2026Est. completion: Jan 202720 patients
Phase 2/3Not Yet Recruiting
NCT05963204GaldermaSculptra and Alastin Restorative Skin Complex

A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen

Start: Jul 2023Est. completion: Mar 202421 patients
N/ACompleted
NCT04065035ReVision TherapeuticsTopical Body Firming Moisturizer

A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming

Start: Dec 2018Est. completion: Jul 201946 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.